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ABSTRACT

EXPLORING VARIABLES OF POST-OPERATIVE DEPRESSION
IN CARDIAC SURGICAL PATIENTS

By
Mary Malitas
December 2016

Dissertation supervised by Dr. Kathleen Sekula
Evidence supports that both psychological and psychosocial factors, such as
uncertainty and depression contribute to the incidence of poor health outcomes in cardiac
patients undergoing surgery. Uncertainty and depression can illicit feelings of loss of
control and have a direct effect on the health related quality of life of patients undergoing
cardiac surgery. Known predictor variables were identified and proposals for further
research were explored in order to establish a standard of care for this population related
to their psychological health. This research attempts to highlight those variables that
impact the long-term outcomes of cardiac patients. In addition, the role of serotonin
levels is explored as a function of identifying depressive symptomatology before and
after surgery. Pre-operative assessment of these variables may assist in the development
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of interventional strategies that can be applied by health care providers in order to
identify those patients at risk and to ultimately improve health outcomes.
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CHAPTER ONE

Introduction
Coronary artery bypass grafting (CABG) surgery is the recognized treatment for
those patients with symptoms of ischemic heart disease identified through coronary
angiography not amenable to percutaneous intervention. The goals of the surgery are
related to reducing morbidity and mortality from future coronary risk factors, improve
quality of life, and prolong life expectancy (Hawkes, Nowak, Bidstrup, & Speare, 2006;
McKenzie, Simpson, & Stewart, 2010). Through the literature, there is corroboration that
psychosocial factors including those of uncertainty and depression contribute to the
development of depressive symptomology. These factors along with a sense of loss of
control have a direct effect on the individual's health related quality of life.
Psychological distress manifested by feelings of uncertainty and symptoms of
depression have been reported as pre-operative correlates affecting health outcomes after
surgery (Fitzsimons, Parahoo, & Stringer, 2000; Koivula, Tarkka, Tarkka, Laippala, &
Paunonen-Ilmonen, 2002; McCormick, Naimark, & Tate, 2006) . "Better understanding
of the mood predictors, such as depression and anxiety, should help the identification and
treatment of at- risk patients in this clinical population" (McKenzie et al., 2010, p. 75). In
addition, a review of the literature examined the function of serotonin as a
neurotransmitter in the body. Its correlation to depressive symptoms is not fully
understood and warrants further exploration and assessment in this population (Elder &
Mosack, 2011; Lacasse & Leo, 2005; Lemonick, 1997; Wankerl, Wust, & Otte, 2010).
Presently, most health care clinicians do not perform a focused assessment of the
patient related to their psychological well-being with consideration to factors that could
influence their recovery. Within the cardiac surgery population, there is no established
1

standard of care or core measure that assesses pre-cardiac surgery patients who are at risk
for depression post-surgery.
The objective of this research inquiry was to evaluate associative factors in the
pre-operative phase that could potentiate post-operative depression. Specifically, the
research examined the influence among uncertainty and serotonin levels on postoperative depressive symptomology. This information demonstrated the need for
development of future research into interventional strategies by health care clinicians to
optimize patient outcomes.
The aim of the research was the investigation of pre-operative uncertainty,
depression, and serotonin levels as associative factors of post-operative depression in the
cardiac surgical population. Specifically, this inquiry explored the relationship between a
pre-operative serotonin level, levels of uncertainty using Mishel's Uncertainty in Illness
Scale (MUIS), and depressive symptomatology measured by Beck's Depression
Inventory (BDI) as associative (predictive) factors in post-operative depression.
The long-term goal of this research would be to establish standards of practice
based on the findings in order to provide guidelines for assessment, prevention and
treatment in caring for patients undergoing cardiac surgery in order to lessen the negative
impact of depression post surgically. The results of this inquiry support the call for
research related to nursing strategies to guide practice, affect pre-operative teaching to
the patient, and improve postoperative outcomes. The development of evidence-based
practice will change the delivery of care.
The research questions that were addressed are:
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1. What is the relationship between selected demographic variables and postoperative depression in a cardiac patient undergoing surgery?
2. What is the relationship between pre-operative serotonin levels and depression
scores measured pre-operatively (Time 1), at 4 weeks post-operatively (Time 2),
and at 12 weeks post-operatively (Time 3)?
3.

What is the relationship between scores on the Beck Depression Inventory
compared pre-operatively and post-operatively in the cardiac surgical patient?

4. What is the relationship between scores on the Mishel Uncertainty in Illness Scale
in comparison to scores on the Beck Depression Inventory pre-operatively, at 4
weeks, and at 12 weeks post-operatively?
5. Is a combination of selected socio-demographic variables, pre-operative serotonin
level, uncertainty, and depression scores a predictor of post-operative depression
at 4 weeks and 12 weeks post-operatively?

Background and Significance
The investigation of uncertainty, depression, and their clinical sequelae in the
cardiac surgical participants in this study focused on pre-operative evaluation with follow
up during the post-operative course. Research in cardiac surgical patients demonstrated
that post-operative depression is linked with an increase in morbidity, mortality, and
l increased readmissions for cardiac events (Blumenthal, et al., 2003; Oxlad,
Stubberfield, Stuklis, Edwards, & Wade, 2006; Tully & Szackely, 2013). In addressing
potential causes of depression, the effect of serotonin, a neurotransmitter, emerged as a
potential correlate to symptoms of depression. Much of the research related to serotonin
as a direct contributor has been controversial; centered mainly on therapeutic treatment
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options after the diagnosis. The role serotonin levels may play in identifying those
individuals at greater risk for depression related to illness or surgery is worthy of further
exploration. A review of the literature examined the function of serotonin as a
neurotransmitter in the body as well as associated research studies that have investigated
the measurement of serotonin levels and depressive symptoms within cardiac disease
processes (Lett et al., 2004; Meltzer, 1989; Sanner & Frazier, 2011)
Current literature described a relationship between post-operative psychological
status and recovery in the cardiac patient (Blumenthal et al., 2003; Mallik et al., 2005;
Pignay-Demaria, Lesperance, Demaria, Frasure-Smith, & Perrault, 2003). This research
was conducted to explore the relationship between cardiac surgery and depression, along
with potential predictor variables that may assist in the development of standards of
health care practices for patients undergoing cardiac revascularization.
Theoretical Framework
The mid-range theoretical framework developed by Mishel guided this research
study. The uncertainty in illness theory explains how a patient deals with illness related
events and their outcomes. The theory is based on three themes, antecedents of
uncertainty, which includes stimuli frame, cognitive capacities, and structure providers.
These subtexts refer to how stimuli is perceived, information processed, and how outside
support affects the patient in either a positive or a negative direction. Appraisal of
uncertainty includes inference and illusion, which describes an evaluative process of
uncertainty, based on personal experiences, knowledge, and constructed beliefs affecting
outlook. Lastly, coping with uncertainty includes the concepts of danger, opportunity,
coping and adaptation (Mishel, 1981, 1988; Mishel & Clayton, 2008). Each of these
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processes influences the evolution of uncertainty into a positive or negative outcome.
The uncertainty in illness theory highlights the process a patient may experience when
dealing with either an acute illness or a chronic condition.

5

CHAPTER TWO
Chapter 2 includes the first manuscript. A thorough review of the literature was
conducted and the manuscript was written to meet the requirements for the target journal.
The manuscript was submitted, reviewed by the editorial board reviewers, and revisions
are currently in process for resubmission.
Manuscript 1

Introduction
Coronary artery bypass grafting (CABG) surgery is the recognized treatment for
those patients with symptoms of ischemic heart disease identified through coronary
angiography not amenable to percutaneous intervention. The goals of the surgery are to
reduce morbidity and mortality from coronary risk factors, improve quality of life, and
prolong life expectancy (Hawkes et al., 2006; McKenzie et al., 2010). The literature
clearly provides evidence that both psychological and psychosocial factors including
those of uncertainty and depression may contribute to the incidence of poor health
outcomes in this population (McCormick et al., 2006; White & Frasure-Smith, 1995).
Uncertainty and depression can illicit feelings associated with a loss of control and have a
direct effect on the health related quality of life beginning in the pre-operative phase and
often continuing through the post-operative state (Fitzsimons et al., 2000; Gallagher &
McKinley, 2009; So & La Guardia, 2011).
Psychological distress manifested by symptoms related to uncertainty and
depression have been reported as pre-operative correlates affecting health outcomes after
cardiac surgery and coronary angioplasty (Fitzsimons et al., 2000; Koivula et al., 2002;
McCormick et al., 2006). Recognition of these psychological risk factors may assist the
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clinician with early identification of patients at risk for depression within the cardiac
surgical population (McKenzie et al., 2010).
This review explored the role of preoperative uncertainty and depression on
quality of life in patients with coronary artery disease. Evidence of the negative effects
of post-operative depression including an increase in morbidity, mortality, and
readmissions for cardiac events was addressed (Blumenthal et al., 2003; Oxlad et al.,
2006; Tully, Baker, Turnbull, Winefield, & Knight, 2009). An assessment of the patient
and their psychological wellbeing with consideration of factors that may influence
recovery in the post-operative period was reviewed. An examination of the role of
serotonin, a neurotransmitter, which is often cited relative to depression, may assist to
correlate findings with those of uncertainty and depression. This review examined the
current state of science regarding the relationship between depression, uncertainty,
serotonin, and patients undergoing cardiac surgery. The lack of pre-surgical assessment,
which may result in negative health outcomes, presents a need for further research and
evaluation of pre-operative psychological and psychosocial well-being in this population.

Cardiac Surgery and Depression
William Harvey, in 1628, first suggested the link between the "mind and the
heart" in describing both positive and negative emotions with their correlational effects
on the heart (Rumsfeld & Ho, 2005). However, it was not until over three centuries later
that research studies began to establish sound evidence for this relationship. It was first
reported in the 1980's that a relationship existed between cardiovascular patients with
major depression and the increased risk of cardiovascular events, leading to major cardiac
surgery, and increased mortality rates (Peterson et al., 2002).
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The varying etiologies of post-operative depression include reports of anxiety,
stress of cardiac surgery and patient co-morbidities (Hawkes et al., 2006; Timberlake et
al., 1997). Researchers have reported pre-operative depression as a predictor of negative
psychological effect in the post-operative phase. Similar results were found among preoperative depression scores and quality of life scores after cardiac surgery (Mallik et al.,
2005; Peterson et al., 2002; Timberlake et al., 1997; Tully et al., 2009).
In the early 1980's, Merle Mishel developed a theory related to uncertainty in
illness and its effect on the overall well-being of the individual. Her initial work in
uncertainty was influenced by the work of Lazarus (1974) on stress and coping. Further
guided by the work of Bower (1978) and Shalit (1977), Mishel continued to investigate
the importance of the cognitive state in stress response (Mishel & Clayton, 2008; Smith
& Liehr, 2008). The theory of uncertainty in illness consists of three major themes that
include antecedents of uncertainty, how past illness experiences affect patient ability to
deal with present situation;” appraisal of uncertainty, which places value on present
uncertainty, and coping with uncertainty for adaptation. (Mishel, 1981, 1988; Mishel &
Clayton, 2008).
Personal experiences reflect behaviors exhibited as coping mechanisms to control
environmental stimuli in terms of a diagnosis of acute illness or living with a chronic,
sometimes life-threatening illness. Mishel defined uncertainty as an "inability to
determine the meaning of illness-related events, occurring when the decision maker… is
unable to predict outcomes accurately" (Alligood & Tomey, 2010, p. 601). This
definition highlights the interpretation and understanding of the diagnosis by the
individual. Mishel offers an assessment of cognitive aspects of uncertainty based on the
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individual's inherent nature, exposure to previous stimuli, and their outcomes. She
utilizes the terms danger or opportunity to evaluate whether a person demonstrates a
positive or negative response to uncertainty as an indicator of each person's capacity for
adaptation to illness (Mishel, 1988). Her research revealed the effects of uncertainty in
many different disease populations including those with cardiac disease (Eastwood,
Doering, Roper, & Hays, 2008; McCormick et al., 2006; White & Frasure-Smith, 1995).
In 2006, McCormick and colleagues conducted a cross-sectional, descriptive,
correlational study investigating both psychological and physical factors influencing
patients awaiting a cardiac surgical procedure. In this study, the theoretical framework of
Mishel's Uncertainty in Illness provided the guiding principles in describing the manner
in which patients assimilate information and develop an understanding of their illness. In
this mixed methods study, forty-two patients were assessed for levels of uncertainty
(Mishel's Uncertainty in Illness Scale), anxiety (Graphical Anxiety Rating Scale),
symptom distress (symptoms frequency and symptom distress Scale), and functional
status (Kansas City Cardiomyopathy Questionnaire Subscales). In addition, the influence
of length of time waiting for surgery on psychosomatic condition was explored. Of those
forty-two patients, twenty-six agreed to be interviewed regarding their experience while
waiting for surgery.
The data revealed that length of time awaiting surgery and its effect on
psychological factors did not reach statistical significance; however, based on interviews,
responses, and extrapolated themes, the investigators concluded that patients experienced
both positive and negative feelings based on the patient response at a particular moment.
Highly significant correlations were found between functional status and anxiety,
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symptom distress, and physical limitations. While no significant differences were
observed between the length of time (<2 months, 2-4 months, and > 4 months), symptom
frequency scores and anxiety, levels tended to increase with time along with a
deterioration of social and physical functional status as waiting time increased. Findings
suggest that regular assessment of symptoms and functional status during the waiting
period may help to stabilize the patient's cardiac status. The researchers recommend that
further research be conducted in a larger sample in a time series including both preoperative and post-operative phases of care. This study highlighted the benefit of
performing a baseline psychological profile prior to major cardiac surgery with continued
evaluation through the post-operative period. This information may assist in identifying
pre-operative characteristics of danger or opportunity that may affect patient outcomes
(McCormick et al., 2006; Mishel, 1988).
Magni and colleagues (1987) conducted a prospective study, which revealed
those patients with a higher psychological distress score prior to cardiac surgery were
more likely to have higher scores on depression and anxiety one year after surgery.
Ninety-nine patients were followed over the course of one year after their cardiac
surgery. Approximately 25% of patients had continued symptom distress, high scores on
anxiety and depression scales, at one year after surgery. These researchers also relayed
the importance of the need for further preoperative evaluation and support prior to
revascularization. Similarly, Frasure-Smith and colleagues (1993) reported an increased
mortality among patients who were depressed at time of a cardiovascular event
(Rumsfeld & Ho, 2005).
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Another research study, nine hundred and sixty three patients requiring coronary
artery bypass graft (CABG) were found to have higher scores of depression that
translated into negative health outcomes after 6 months (Mallik et al., 2005). Patients
underwent a baseline evaluation of both physical and psychological status prior to their
scheduled procedure followed by an assessment utilizing a depression scale postoperatively. In this study, depression was characterized as an independent risk factor of
poor health outcomes six months after coronary artery bypass surgery; demonstrating that
depressive symptoms were a better measure of surgical health outcomes than comorbidity factors such as left ventricular function, diabetes mellitus, heart failure, and
myocardial infarction (Mallik et al., 2005).
Clearly, studies have shown the link between these pre-operative factors specific
to stress of illness, uncertainty, and pre-operative depression and the overall quality of
life of patients' post-operatively. These types of stressors, which can result in a life style
change or modification, can trigger a depressive response. The adaptive or maladaptive
response of the patient to the cardiac surgical procedure was the focus in addressing the
problem and improving patient outcomes (Lauermann, 2000).
In 2011, Seriani discussed the diathesis-stress model of depression relating the
genetic and biochemical (diathesis) individual response to stressful event. This
relationship may consider the effect of uncertainty, baseline evaluation of depression, and
the neurotransmitter serotonin in the pre-operative phase before cardiac surgery.

Depression
The common feature of all depressive disorders is the presence of sad, empty, or
irritable mood, accompanied by somatic and cognitive changes that significantly affect
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the individual’s capacity to function (APA-5, 2013, p. 155). The American Psychiatric
Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria is
designed to be utilized by clinicians to assist in a more reliable diagnosis of mental
disorders (2013). The DSM-5 assists in delineating depressive disorders based on
symptoms that may limit a person's functional capacity. A sub-category of major
depressive disorder labeled Depressive Disorder Due to Another Medical Condition
allows for a consideration of symptoms and associated factors related to the specific
episodes along with a timeline for evaluation (APA-5, 2013). A thorough assessment of a
patient’s history of depression is warranted when determining their status related to
depression at the time of cardiac surgery.
In a study by the Centers for Disease Control (2010), the World Health
Organization in 2004 reported depression as the third leading cause of disability in higher
income countries (USDOH, 2010). Similarly, in 2009, the Annals of Internal Medicine
employed a task force, which revealed consistent findings labeling depression among the
leading causes of disability in persons age 15 and older (US Preventive Task Force,
2009). The National Institute of Mental Health (NIMH) estimates that 1 to 5% of older
adults experience depression and that number rises to 11.5% for hospitalized patients.
Further data revealed that in 2012, an estimated 16 million adults (age 18 or older)
experienced one major depressive episode; this accounts for 6.9% of all adults in the
United States (NIMH, 2012). Early recognition and treatment play an integral role in
overall patient health and outcomes.
Depression has been well documented when viewed within the context of medical
healthcare with its effects on outcomes. Research is ongoing looking at underlying

12

causes of depression and its association with medical conditions. Symptoms typically
associated with depression such as sadness, anxiety, fear, and loss of control are among
the clinical signs either voiced or silenced by depression. Narrowing the focus of postoperative depression to its significance within the cardiac population demonstrated the
interrelatedness of pre-operative evaluation and its association post-operatively in
patients receiving cardiac care and undergoing cardiac revascularization (Gallagher &
McKinley, 2009; Mallik et al., 2005; Peterson et al., 2002; Timberlake et al., 1997; Tully
et al., 2009). Factors such as social support, psychological baseline, and physical
response to the post-operative state play a role beginning at initial diagnosis through
cardiac recovery and after care.
The Beck Depression Inventory (BDI) is a 21-question multiple-choice inventory
that can be completed by the patient or by the clinician. The BDI is among the most
widely used instruments for measuring the severity of depressive symptoms. The tool is
designed for individuals 13 and older, with items relating to symptoms of depression
including hopelessness and irritability, thought processes such as guilt or feelings of
being punished, physical fatigue, weight loss or gain, and lack of interest in sexual
activity. It utilizes evaluation of depressive symptomology with each category
representing a specific expression of depressive behavior (Beck, 1972).
There is ample research and clinical evidence that the effects of illness on an
individual may have undesirable consequences. Further areas of interest for exploration
are the possible connection between pre-operative uncertainty in illness utilizing the
theoretical framework established by Mishel; depression, measured by the Beck
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Depression Inventory; and the measurement of serotonin levels within the cardiac surgery
population.

Serotonin
In addressing potential causes of depression, the effect of serotonin, a
neurotransmitter, emerged as a potential correlate to the diagnosis of depression. Much
of the research related to serotonin as a direct contributor has been controversial; centered
mainly on therapeutic treatment options after the diagnosis. The role serotonin levels may
play in identifying those individuals at greater risk for depression related to illness or
surgery is worthy of further exploration. A review of the literature examined both
scientific details of the workings of serotonin as a neurotransmitter in the body as well as
associated research studies that have investigated the measurement of serotonin levels
and depressive symptoms within certain disease processes.
A person's genetic makeup coupled with the advent of a stressful situation has
been linked with increased risk of depression. Each person is uniquely different in his or
her truest form; abnormalities within this genetic makeup have been cause for
investigation into the manifestations of one's behavior. The available amount of
neurotransmitter within the synapses of certain areas of the brain makes a difference in
expression of behavior. Genetic mutations of the serotonin molecule, called
polymorphisms, are reflected in the gene description of the short or ‘s’ allele or the long
‘l’ allele where alleles represent different forms of the gene that can lead to variations in
the structure of the protein resulting in changes in transmission of information (Medina,
2004, p. 18).
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Elder and Mosack (2011) define and discuss important concepts in developing a
basic understanding of genetics and depression. Hereditability is the amount of variation
of a trait that can be attributed to genetic influences. Evidence has been presented linking
individuals with the s allele as being at greater risk of developing depression related to
environmental influences than those without this particular allele. If an individual carries
either one s allele or two, the risk of major depressive disorder is greater (Elder &
Mosack, 2011).
The role of neurotransmitters and their receptors play an integral role in areas
related to brain activity and the body's response. This intricate network within the brain
is responsible for maintaining homeostasis of neurologic activity throughout the body.
Serotonin (5-HT) is discussed due to its association with behavior disorders at lower and
higher levels ranging between depression and anxiety (Blows, 2000). 5-HTT, the
serotonin transporter protein was reviewed related to its involvement in the transport and
reuptake of serotonin. This information provided insight into the role of serotonin and its
use in conjunction with psychometric tools to assist in the early identification of those
patients at risk for post-operative depression in the cardiac surgical population.
Serotonin (5-HT) is important for its role in the cognitive and affective behaviors
of mood, sleep, appetite, and body system functions. It is part of the amine group of
neurotransmitters found within the raphe nuclei on the pons, medulla, and the brain stem
(Blows, 2000; Valenzuela, Puglia, & Zucca, 2011) . The serotonin pathway leads to
neuronal pathways within our body with distribution areas in "multiple centers of the
cerebrum, the limbic area, and the basal ganglia" (Blows, 2000, p. 234).
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Serotonin is classified as a monoamine. An associated monoamine theory of
depression, first discussed forty years ago, hypothesizes this link between decreased
levels of circulating serotonergic activity as a causative factor related to depression
(Sanner & Frazier, 2011)
Blows (2000) discusses the production of serotonin from the amino acid,
tryptophan, which can be found in dietary sources. The passing of tryptophan through
the blood brain barrier and its conversion to serotonin relies on the enzymatic processes
occurring within the neuronal pathways. Deficiency in any of the vitamins that aid in the
conversion may cause changes in behavior (Medina, 2004). Sanner and Franzier (2011)
relate factors that may be a resultant cause of the deficiency; these include dietary
depletion of tryptophan, inhibition of enzymatic processes of conversion, decrease in
serotonin receptors or a non-working transport system. The 5-HT receptor sites and their
pre-synaptic and post-synaptic function play an important role within these transport
systems. The conversion process in which tryptophan is converted to 5-HT with
subsequent metabolism allows for 5-HTT to perform as the transporter protein.
The 5-HTT gene is the transport protein for serotonin. It plays an essential part in
"regulating the concentration of serotonin in the brain" (Medina, 2004, p. 17). The role
of 5-HTT is in the reuptake of serotonin in the cell thereby maintaining a state of
concentrated equilibrium that allows for expression of the gene.
Figure 1. Represents the activity within the transport system where serotonin is
being released by the pre-synaptic area and binding with the receptors in the postsynaptic
cells. It appears that any factor that may alter the course of activity via transport or
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uptake would have an effect on the circulating levels of serotonin resulting in a potential
change in behavior.
Figure 1. Action of Serotonin and the Serotonin Transporter.

Schematic drawing of the neurotransmitter serotonin being released from the presynaptic
cell and binding to the receptors on the postsynaptic cell. 5-HTT encodes the protein
labeled reuptake transporter. Image from https://dynamichealthresources.com. Permission
granted by Dynamic Health Resources.
This information assisted in providing insight into the effect that serotonin has on
individual behavior. Baseline psychosocial evaluation along with serotonin levels in the
pre-operative phase may assist in identifying those at increased risk; individuals that may
be on the cusp of uncertainty and depression before cardiac revascularization.
The cumulative result of the information provided within the review revealed
components that may have an effect on the overall health outcomes of those individuals
undergoing cardiac surgery. Further research into the components of uncertainty,
depression, and serotonin level may lead the nursing health care team into strategic
development of pre-operative tools to assist with early detection and intervention. These
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areas were further explored to gain information and impart knowledge to improve health
outcomes in this population.
Current practice guidelines and clinical pathways do not proactively assess
patients who are awaiting surgery for history of depression or uncertainty. This accounts
for a missed opportunity for early identification, education, and intervention (Blumenthal
et al., 2003; Lett et al., 2004; Pignay-Demaria et al., 2003). There is no measurement
tool in use pre-operatively to gauge those patients at potential risk for poor psychological
outcomes after surgery, thereby affecting post-operative recovery and quality of life.

Nursing Implications
Evidence Based Screening and Assessment
Presently, most health care clinicians do not perform a focused assessment of the
patient related to their psychological well-being with consideration to factors that may
influence their recovery. Within the cardiac surgery population, there is no established
standard of care or core measure, which assesses the pre-cardiac surgery patients with
regard to risk for depression post-surgery. Because there are no established parameters
for this particular assessment, the exploration of influencing factors was the focus of
further investigation.
Call for Research
Current practice guidelines and clinical pathways do not proactively assess
patients who are awaiting surgery for history of depression or uncertainty. Gallagher and
McKinley (2009) discussed the need for a more proficient method of assessment and
identification of psychological symptoms in this patient population that may affect
outcomes. Not establishing guidelines for assessment and treatment of psychological
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symptoms transpires into a missed opportunity for early identification, education, and
intervention (Blumenthal et al., 2003; Lett et al., 2004; Pignay-Demaria et al., 2003).
There is no standard measurement tool in use pre-operatively to gauge those patients at
potential risk for poor psychological outcomes after surgery, thereby affecting postoperative recovery and quality of life. Panagopoulou and colleagues (2005) found that
those individuals with psychological risk prior to cardiac surgery had worse health
outcomes in the post-operative time period at one month and six months (Panagopoulou,
Montgomery, & Benos, 2006). This finding speaks to the need to explore opportunities
for risk stratification or modification within this population.

Summary
The number of coronary artery bypass graftings (CABG) in the United States,
according to data from 2010, was approximately 395,000 not including valve procedures,
or valve procedures plus CABG (www.cdc.gov). This information coupled with the
literature that supports the evidence of depression in this population of patients presented
an opportunity for further exploration into the role of pre-operative evaluation of
uncertainty, depression and serotonin. Uncertainty, as discussed through the theoretical
framework of Mishel, seeks to establish whether the patient views illness as a danger or
opportunity. This information may assist in determining an individual's adaptation to
illness. The BDI assesses severity of depressive symptoms by reviewing patient
responses at the particular point in time in which the BDI is completed. The use of both
of these tools offers valuable information that in conjunction with the biomarker measure
of serotonin may assist in the development of a standard of care to recognize early signs
and symptoms pre-operatively. This pre-operative evaluation may include nursing as an
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important link in identifying those at risk, informing the health care team, and working on
interventional strategies to promote positive health outcomes.
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CHAPTER THREE

Research Design
A descriptive, correlational, prospective design was used to conduct this study.
The relationships among specific variables as associative factors related to post-operative
depression were explored. The importance of this study lies in the fact that at present,
there is no standard of care in the evaluation of depressive symptoms as well as
uncertainty in the cardiac surgical population pre-operatively and post-operatively.
This study examined depression scores with the use of the Beck Depression
Inventory (BDI), levels of uncertainty as measured by Mishel's Uncertainty in Illness
Scale (MUIS), along with the measurement of serotonin level, a neurotransmitter in the
brain. These variables were explored relative to their impact on post-operative
depression in patients undergoing cardiac surgery using a descriptive, correlational,
prospective design.
Setting
The setting was the outpatient Cardiovascular Surgery Department at the
University of Pennsylvania-Presbyterian Hospital in Philadelphia, Pennsylvania. The
practice consults with more than 150 patients per month including pre-operative and
postoperative patients. These numbers yield an elective surgical population of 50-72
surgeries per month.
Population
The population under study included participants undergoing elective cardiac
surgical procedures for symptoms related to coronary artery disease and/or valvular heart
disease. The inclusion criteria included men and women age 21 or older requiring cardiac

21

surgery; with no exclusions related to ethnicity, race, or religion. Exclusion criteria
included those with a diagnosis of mental disorder, anti-depressant therapy, non-English
speaking persons, and those diagnosed with a mental handicap.
Power Analysis
No previous research was conducted using the combination of variables explored,
therefore, the two-tailed significance criteria was set at 0.05 and the power at .80. The
results for the projected sample size that could achieve these criteria was 52 participants.

Measurements
Demographics
Demographic data including type of surgical procedure, gender, age, marital
status, years of education, annual household income, history of depression, history of
certain types cancer were collected (Appendix A). Variables measured included
depressive symptomatology, levels of uncertainty, and serotonin levels. The predictor
variables were uncertainty, depression and serotonin. The outcome variable was
depression.
Beck's Depression Inventory (BDI)
The BDI (Appendix B) was utilized for the evaluation of depressive
symptomology. Permission for use was granted through the American Psychological
Association (APA), which owns the copyright to the original scale. The BDI is based on
categories of symptoms and attitudes (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961).
Each category represents a specific expression of a depressive behavior. Behavior
responses were scored on a self-report scale. The 21-question inventory had a maximum
score of 63 and a minimum of zero. Depression scores were classified based on specific
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parameters established within the BDI. Higher-level scores reflected greater depressive
symptoms. These ranges reflected mild (11-16), moderate (21-30), severe (31-40), and
over 40 classified as severe depression. Scores above 17 reflected a correlation with
depressive symptoms that would require medical treatment. Beck and colleagues (1961)
in their original work established reliability and validity through their administration of
the scale and clinical acumen. The BDI has established itself as a reliable and valid
standardized measure of assessment of depressive symptoms within a variety of
populations. For example, many studies of post-operative outcomes for depression were
evaluated using the BDI in a population of cardiac patients who had undergone CABG
(Connerney, Sloan, Shapiro, Bagiella, & Seckman, 2010; Foss-Nieradko, Stepnowska, &
Piotrowicz, 2012; King, Colella, Faris, & Thompson, 2009)
The BDI was administered to the participant after informed consent had been
obtained. This was a paper and pencil collection method with the questionnaire taking
approximately 15 minutes to complete. An initial assessment was obtained on the
scheduled day of pre-operative instruction and testing for the participant. Data were
entered into a computer data system under the participant number for statistical analysis.
Further administration of the tool took place at 4 weeks and 12 weeks post-operatively.
Mishel's Uncertainty in Illness Scale (MUIS)
The MUIS (Appendix C) was used to measure uncertainty in this population. The
scale is based on her theory developed in 1981, which corresponds to an individual's
adaptability to a diagnosis of illness and how the individual interprets and integrates this
information. Uncertainty related to an illness may have a negative trajectory with
physical and psychological effects on both the patient and the recovery process. MUIS, a
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structured, self-administered tool, was utilized in the quantitative evaluation of
participant responses related to illness. Based on a thirty-three question Likert scale,
scores were analyzed on uncertainty related to "recognition, accommodation, and
perception” (Mishel, 1982, p.259). In a previous study in a sample of forty-two patients
undergoing elective CABG surgery, uncertainty measurements for those patients awaiting
surgery were at moderate levels with an associated decrease in quality of life
(McCormick et al., 2006). Similarly, uncertainty and quality of life examined both pre
and post coronary angiography at one year revealed that baseline uncertainty affected
patient quality of life (Eastwood et al., 2008).
Permission (Appendix D) was obtained from Dr. Merle Mishel for use of her
scale in this research study. The Adult Form of the MUIS had explicit instructions
guiding the participant to evaluate how they were feeling on the particular day in which
they were responding to the questionnaire. The scale required a response to each
question. The 5-point Likert format ranges from (0) strongly disagree to (5) strongly
agree. Cumulative scores obtained through the questionnaire ranged from 0-165, with
higher scores indicating greater uncertainty. Cumulative numerical scores corresponded
to mild (0-54), moderate (55-110), and high (111-165) levels of uncertainty.
A detailed report of the work conducted using the scale, including its reliability
and consistency in different patient populations is offered in the tool's manual. The scale
has many different forms and is used internationally in a wide variety of disease
processes. The adult form, looking at the cardiac population, in terms of reliabilities and
Coefficient Alpha for categories of ambiguity, complexity, inconsistency, and
unpredictability within the questionnaire were in the range of 0.73-0.93 overall (Mishel
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Manual). The questionnaire related to uncertainty in illness (MUIS) was administered by
paper and pencil method to the patient at each established time point. Overall, total scores
on the MUIS were utilized in the data analyses.
Serotonin
This neurotransmitter and biomarker, was collected via a blood sample at the
time of patient's routine pre-operative blood work. Approximately, 4 ml of blood was
drawn in a separate tube with preservative added to ensure stability of the specimen. The
blood specimen was identified with the participant study number. No identifying
information was labeled on the specimen. Specimens were discarded at the conclusion of
the study by reference laboratory staff. These specimens were sent to ARUP, a national
reference laboratory, for analysis. The reference range utilized by the lab was 50-220.
The results of the blood studies were categorized as nominal data with scores falling
within a range of low to high based on the parameters established by the lab.

Research Procedure
Once approvals from the appropriate Institutional Review Boards were obtained,
recruitment activities began. Participants who met the inclusion criteria were identified
through the cardiovascular office staff and surgeons within the department. Once
identified, the study was explained and the patient's interest in participation was
determined. Reassurance in the privacy and confidentiality of all matters related to the
study were clearly outlined in the consent for participation. Participants were identified
on all forms throughout the study by number only. Participants were asked to provide
their address for future mailings related to the research study. Specific identifying
numbers correlated name and address for the purpose of this future communication.
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Participants were asked their preferred method of communication, via telephone or email,
for follow-up with questionnaires if needed. Participants were not identified by name in
any reports within the study. Participants were informed that they may withdraw from the
study at any time and that any data collected to that point would be destroyed.
Patients scheduled for coronary artery bypass grafting, valve replacement, or both
bypass grafting and valve replacement were identified as potential participants through
the Cardiovascular Surgery Department. Upon meeting with the cardiovascular surgeon
in consult, the opportunity to participate in the study was discussed with the patient by
the surgeon. If the patient was agreeable to receive further information, this primary
researcher or a research assistant was on hand to provide a detailed description of the
study and answer any questions related to participation.
Data were gathered at set intervals established prior to the initiation of the study
corresponding to the pre-operative phase, 4 weeks post-operatively, and 12 weeks postoperatively. Preoperative data were collected in the physician’s office in the surgical
department. Surveys were distributed to participants at 4 weeks and 12 weeks after
surgery, the 4 week surveys were either mailed back or brought with them to their fourweek post-operative visit. The twelve-week survey was mailed back by the patient, as
there was no in-person visit. Blood samples were collected in the outpatient lab center
both preoperatively and at four weeks to determine serotonin levels. Patients did not
return for in-person twelve-week visits, therefore serotonin levels could not be evaluated
at this time point.
A research assistant was available to review the details of the study with each
participant. This informational process took approximately 15 minutes. If the patient
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agreed to participate in the study, the nurse practitioner working in the physician’s office
then met with the participant and obtained informed consent (Appendix E). The
demographic data sheet, the BDI, and the MUIS were explained to the participant and
then administered by the nurse practitioner. The surgical date was then agreed upon by
the patient and the surgeon.
The average time for completion of the demographic data and the two scales was
approximately 30 minutes. Data were entered into a computer data system under the
participant number for statistical analysis.
After discharge from the hospital, questionnaires were sent to the participant at
home for completion with return postage guaranteed via USPS Priority Mail. Once the
follow-up questionnaires were returned, questionnaires were stored in a locked cabinet
and data were entered into a software program for statistical analysis on a passwordprotected computer.
A sample of blood to measure serotonin was obtained at the same time that
standard pre-operative blood work as required by the hospital was collected by drawing
an extra tube of blood from the patient, Blood specimens were sent by the University of
Pennsylvania Hospital to ARUP, the off-site reference laboratory, for analysis through a
specific research protocol. ARUP, the reference lab, was the designated off-site
laboratory that conducted this specific test. Serotonin levels were measured by highpressure liquid chromatography. A serum separator tube was used for collection. The
cost to run this test was incurred by the primary research team. The expense through
ARUP was $40.00 per specimen. This was the first of two blood draws required as part of
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the research study. The second blood draw at 4-weeks post-operative was drawn and
analyzed in the same way as the first blood draw.

Data Analysis
Data screening in this research analysis played an integral role in the accuracy of
the reported data results. Tabachnik and Fidell (2013) discussed the importance of
identification and resolution of factors that may produce erroneous results. Initially, a
thorough review of completed demographic data and the two surveys collected was done
prior to its inclusion in the database. An individual on the research team with data entry
experience then checked and cleaned the data set. Missing data were assessed and
consideration was given to factors that could reveal an arbitrary link or particular pattern
within the data set. The final database was reviewed with the statistician to determine
that data were entered properly and that missing data was handled properly.
Contact information was obtained to enable the research assistant to communicate
with the participant at the designated time intervals if questionnaire data had not been
returned. If participant wished results of the study, they were to contact the primary
researcher.
IBM SPSS Version 23 was used for analysis of the data. Descriptive statistics
were run on all variables, including frequencies and central tendencies of the variables of
depression, uncertainty in illness, and serotonin with consideration of the dependent
variable of depression scores. This information determined means and standard
deviations for each predictor. Analysis also revealed the significant bivariate correlations
within the data set.
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To assure the integrity of the analysis, assumptions for multiple regression
analyses were tested. Only those predictors that had relationships with the outcome were
included in the model. Data were tested and met the assumptions of normal distribution.
Tolerance values for all predictors were greater than 1-R² indicating that the assumption
of no multicollinearity between the predictor variables was not violated. Adequate
sample size would decrease the risk of Type II error. Multivariate linearity was assessed
identifying the relationship between depression scores and the variables of uncertainty
and serotonin.
Multiple regression analyses were used to determine if a relationship exists
between the pre-operative measurements of depression, uncertainty in illness, and
serotonin levels with the occurrence of post-operative depression in cardiac-surgical
patients. The independent variables including depression, uncertainty, and serotonin
were evaluated utilizing the tools previously discussed. Depression scores were
classified based on the specific parameters established within the BDI guidelines.
Cumulative scores for the Uncertainty in Illness scale were obtained through Likert scale
format. In addition, serotonin levels were interpreted using nominal scores according to
specific parameters identified by the laboratory.
Timeline
The recruitment phase took place over the course of approximately four months.
Collection of data at specified intervals lasted 12 weeks' time. Data entry was ongoing
through the research process. Once all data were collected, analysis of data and
interpretation of statistical results were conducted. Dissemination of results will
conclude with dissertation and manuscript submission of results of this study.
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Protection of Research Participants
IRB approvals were obtained prior to the initiation of the study. Participants’
privacy and confidentiality were upheld at all times. All data collected from participants
were stored in a locked filing cabinet in the primary investigator’s office. Human subjects
were involved in recruitment and enrollment for this research study. Informed consent
was explained to the participants. Those who wished to participate signed the consent
form and a copy was given to them. Participation in this study was voluntary.
Participants could leave the study at any time for any reason without specification.
Participating in this study had minimal risk but no greater than every day activities. It is
also important to note that an additional tube of blood was drawn along with the standard
preoperative blood work required by the hospital for the first blood specimen required for
this study. Therefore, participants did not need to experience any additional and/or
potential discomfort associated with blood draws. The second specimen of blood
obtained at the 4-week post-operative visit did require a blood draw.
Access to information related to this research study was limited to the principal
investigator, research assistant, and the research chair affiliated with the University.
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Demographic Questionnaire
ID #
1.Scheduled Procedure:
CABG
CABG plus Valve
Valve Surgery Only
2. Gender
a) Male
b) Female
3. Age
4. Marital Status
a) Single

b) Married

d) Widow/Widower

e) Separated

c) Divorced
f) Living with significant

other
5. Years of Education
a) Some High School or less
b) High School graduate
c) Some college or associate degree
d) College graduate/Bachelor's degree
e) Post graduate/professional degree
Annual Household Income
a) Under $15,000
b) $15,000-$24,999
c) $25,000-$34,999
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d) $35,000-$49,999
e) $50,000-$74,999
f) $75,000-$99,999
g) $100,000 and over
Previous episodes of depression: Yes

No

Are you presently taking any anti-depressant medications? Yes

No

If yes, please list._______________________________________
Do you have any history of stomach cancer or thyroid cancer? Yes

No

If yes, please explain. _____________________________________
Do you have any history of psychological disorders? Yes

No

If yes, please explain. ____________________________________
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Beck Depression Inventory
Please select the response that most closely states how you are feeling at the present time.
1.
0
1
2
3

I do not feel sad.
I feel blue or sad.
I am blue or sad all the time and I can't snap out of it.
I am so sad and unhappy that I can't stand it.

0
1
2
3

I am not particularly pessimistic or discouraged about the future.
I feel discouraged about the future.
I feel I have nothing to look forward to.
I feel the future is hopeless and that things cannot improve.

0
1
2
3

I do not feel like a failure.
I feel that I have failed more than the average person.
I feel that I have accomplished very little that is worthwhile or that means
anything.
I feel I am a complete failure as a person.

0
1
2
3

I am not particularly dissatisfied.
I don't enjoy things the way I used to.
I don't get satisfaction out of anything anymore.
I am dissatisfied with everything.

0
1
2
3

I don't feel particularly guilty.
I feel bad or unworthy a good part of the time.
I feel quite guilty.
I feel as though I am very bad or worthless.

0
1
2
3

I don't feel I am being punished
I have a feeling that something bad may happen to me.
I feel I am being punished or will be punished.
I feel I deserve to be punished.

0
1
2
3

I don't feel disappointed in myself.
I am disappointed in myself.
I am disgusted with myself.
I hate myself.

0
1
2
3

I don't feel I am any worse than anybody else.
I am critical of myself for my weaknesses or mistakes.
I blame myself for everything that goes wrong.
I feel I have many bad faults.

2.

3.

4.

5.

6.

7.

8.
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9.
0
1
2
3

I don't have any thoughts of harming myself.
I have thoughts of harming myself, but I would not carry them out.
I have definite plans about committing suicide.
I would kill myself if I could.

0
1
2
3

I don't cry any more than usual.
I cry more now than I used to.
I cry all the time now, I can't stop it.
I used to be able to cry but now I can't cry at all even though I want to.

0
1
2
3

I am no more irritated now than I ever am.
I get annoyed or irritated more easily than I used to.
I feel irritated all the time.
I don't irritated at all at the things that used to irritate me

0
1
2
3

I have not lost interest in other people.
I am less interested in other people now that I used to be.
I have lost most of my interest in other people and have little feeling for
them.
I have lost all my interest in other people and don't care about them at all.

0
1
2
3

I make decisions about as well as ever.
I am less sure of myself now and try to put off making decisions.
I can't make decisions any more without help.
I can't make decisions at all any more.

0
1
2
3

I don't feel I look any worse than I used to.
I am worried that I am looking old or unattractive.
I feel that there are permanent changes in my appearance and they make
me look unattractive.
I feel that I am ugly.

0
1
2
3

I can work about as well as before.
It takes extra effort to get started at doing something.
I have to push myself very hard to do anything.
I can't do any work at all.

0
1
2
3

I can sleep as well as usual.
I wake up more tired in the morning that I used to.
I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.
I wake up early every day and can't get more than 5 hours sleep.

10.

11.

12.

13.

14.

15.

16.
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17.
0
1
2
3

I don't get any more tired than usual.
I get tired more easily than I used to.
I get tired from doing anything.
I get too tired to do anything.

0
1
2
3

My appetite is no worse than usual.
My appetite is not as good as it used to be.
My appetite is much worse now.
I have no appetite at all any more.

0
1
2
3

I haven't lost much weight, if any, lately.
I have lost more than 5 pounds.
I have lost more than 10 pounds.
I have lost more than 15 pounds.

0
1

3

I am no more concerned about my health than usual.
I am concerned about aches and pains or upset stomach or constipation or
other unpleasant feelings in my body.
I am so concerned with how I feel or what I feel that its' hard to think of
much else.
I am completely absorbed in what I feel.

0
1
2
3

I have not noticed any recent change in my interest in sex.
I am less interested in sex than I used to be.
I am much less interested in sex now.
I have lost interest in sex completely.

18.

19.

20.

2
21.
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Mishel Uncertainty in Illness Scale – Adult Form
Instructions
Please read each statement. Take your time and think about what each statement
says. Then place a “X” under the column that most closely measures how you
are feeling TODAY. If you agree with a statement, then you would mark under
either “Strongly Agree” or “Agree”. If you disagree with a statement, then mark
under either “Strongly Disagree” or “Disagree”. If you are undecided about how
you feel, then mark under “Undecided” for that statement. Please respond to every
statement.
1. I don’t know what is wrong with me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

2. I have a lot of questions without answers.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

3. I am unsure if my illness is getting better or worse.
Strongly Agree
(5)
_______
4.

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

It is unclear how bad my pain will be.

Strongly Agree Agree
Undecided
Disagree
Strongly Disagree
(5)
(4)
(3)
(2)
(1)
_______
______
______
______
______
5. The explanations they give about my condition seem hazy to me.
Strongly Agree
(5)
_______
6.

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

The purpose of each treatment is clear to me.
Strongly Agree Agree
Undecided
Disagree
(5)
(4)
(3)
(2)
_______
______
______
______

Strongly Disagree
(1)
______
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7.

When I have pain, I know what this means about my condition.
Strongly Agree Agree
Undecided
Disagree
Strongly Disagree
(5)
(4)
(3)
(2)
(1)
_______
______
______
______
______

8.

I do not know when to expect things will be done to me.
Strongly Agree Agree
Undecided
Disagree
(5)
(4)
(3)
(2)
_______

______

______

______

9. My symptoms continue to change unpredictably.
Strongly Agree Agree
Undecided
Disagree
(5)
(4)
(3)
(2)
_______
______
______
______

Strongly Disagree
(1)
______
Strongly Disagree
(1)
______

10. I understand everything explained to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

11. The doctors say things to me that could have many meanings.
Strongly Agree Agree
Undecided
Disagree
(5)
(4)
(3)
(2)
_______
______
______
______

Strongly Disagree
(1)
______
Strongly Disagree
(1)
______

12. I can predict how long my illness will last.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

13. My treatment is too complex to figure out.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

14. It is difficult to know if the treatments or medications I am getting are helping.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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Disagree
(2)
______

Strongly Disagree
(1)
______

15. There are so many different types of staff; it’s unclear who is responsible for
what.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

16. Because of the unpredictability of my illness, I cannot plan for the future.
Strongly Agree Agree
Undecided
Disagree
Strongly Disagree
(5)
(4)
(3)
(2)
(1)
_______
______
______
______
______
17. The course of my illness keeps changing. I have good and bad days.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

18. It’s vague to me how I will manage my care after I leave the hospital.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

19. I have been given many differing opinions about what is wrong with me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

20. It is not clear what is going to happen to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

21. I usually know if I am going to have a good or bad day.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

22. The results of my tests are inconsistent.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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23. The effectiveness of the treatment is undetermined.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

24. It is difficult to determine how long it will be before I can care for myself.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

25. I can generally predict the course of my illness.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

26. Because of the treatment, what I can do and cannot do keeps changing.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

27. I’m certain they will not find anything else wrong with me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

28. The treatment I am receiving has a known probability of success.
Strongly Agree Agree
Undecided
(5)
(4)
(3)
_______
______
______
29. They have not given me a specific diagnosis.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

30. My physical distress is predictable; I know when it is going to get better or worse.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

31. I can depend on the nurses to be there when I need them.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

32. The seriousness of my illness has been determined.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

33. The doctors and nurses use everyday language so I can understand what they are
saying.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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Disagree
(2)
______

Strongly Disagree
(1)
______

Appendix D
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